Condition: Lichen Planus Pigmentosus · Erythema Dyschromicum Perstans · Ashy Dermatosis of Ramirez · Sponsor: Henry Ford Health System
There are currently no effective treatments for lichen planus pigmentosus (LPP) and erythema dyschromicum perstans (EDP). Tranexamic acid, which may downregulate pigmentation through a reduction in plasmin, has been shown to decrease pigmentation in patients with melasma, another pigmentary disorder. Given that LPP, EDP, and melasma are all disorders of pigmentation with dermal involvement, it is possible that tranexamic acid can also reduce pigmentation in LPP and EDP as well.
This description comes directly from the study's public registry record.
Angela Parks-Miller, RN · 1-313-916-0426 · amiller5@hfhs.org
Jennifer Creasor, RN · 1-313-916-0412 · jcreaso2@hfhs.org
Always discuss trial participation with your own doctor first.
| New Center One | Detroit, Michigan, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04233749